Ginkgo Biloba and Namenda (Memantine) Interactions and Natural Remedy Alternatives
Ginkgo biloba should be avoided when taking Namenda (memantine) due to lack of safety data and potential interactions that could affect drug efficacy, while other natural remedies should be approached with caution due to limited evidence on their safety when used with memantine. 1, 2
Memantine and Ginkgo Biloba Interaction
- Memantine (Namenda) is an N-methyl-D-aspartate (NMDA) receptor antagonist used in the treatment of moderate to severe Alzheimer's disease 3
- The FDA drug label for memantine specifically cautions that "the combined use of memantine hydrochloride with other NMDA antagonists has not been systematically evaluated and such use should be approached with caution" 1
- Ginkgo biloba has been reported to cause spontaneous bleeding and may interact with anticoagulants and antiplatelet agents 2
- While some studies have compared Ginkgo biloba and memantine as separate treatments for cognitive disorders, there is insufficient evidence regarding their combined use 4, 5
- A 2019 network meta-analysis found that Ginkgo biloba extract (EGb761) showed no treatment benefits compared to placebo or cholinesterase inhibitors in Alzheimer's disease patients 4
Memantine and Other Natural Remedies
- The FDA drug label for memantine warns about potential interactions with substances that make urine alkaline, which can reduce memantine clearance by about 80% and potentially increase adverse effects 1
- Some natural remedies can alter urine pH, potentially affecting memantine metabolism and efficacy 1
- Memantine should be used with caution alongside any substances that may act as NMDA antagonists 1
- There is limited evidence regarding the safety and efficacy of combining memantine with natural remedies 6, 7
Evidence on Memantine Efficacy and Safety
- Memantine is recommended for the treatment of moderate to severe Alzheimer's disease in clinical guidelines 3
- Memantine has shown modest benefits in cognition and global function in patients with Alzheimer's disease 3
- In patients with rapid cognitive decline due to Alzheimer's disease, combination therapy of cholinesterase inhibitors and memantine is considered rational and safe, though evidence for recommending this combination is equivocal 3
- Memantine has been associated with adverse events including nausea, dizziness, diarrhea, and agitation, though at rates similar to or lower than placebo in clinical trials 3
- Withdrawal rates due to adverse events with memantine ranged from 8% to 13% in treatment groups compared to 5% to 17% in placebo groups 3
Clinical Recommendations
- Avoid combining Ginkgo biloba with memantine due to potential interactions and lack of evidence supporting safety 1, 2
- Before considering any natural remedy in combination with memantine, consult with a healthcare provider who can evaluate potential interactions 2
- If a patient is taking memantine, monitor for any changes in efficacy or new side effects when starting or stopping any natural remedy 1
- For patients with Alzheimer's disease, evidence-based pharmacological treatments (memantine for moderate to severe disease) should be prioritized over natural remedies with limited evidence 3
- Non-pharmacological interventions such as cognitive training, physical exercise, and brain-healthy diet patterns may be safer alternatives to natural supplements when used alongside conventional treatments like memantine 3
Important Caveats
- Most clinical trials evaluating memantine or natural remedies for cognitive disorders have been of relatively short duration (less than one year) 3
- Clinical trials typically include relatively healthy individuals with specific forms of dementia, so published rates of adverse events may underestimate those seen in clinical practice 3
- The quality of evidence for natural remedies in treating cognitive disorders is generally low, and their interactions with prescription medications are often poorly understood 6, 7
- Patients should always disclose all supplements and natural remedies they are taking to their healthcare providers to minimize the risk of adverse interactions 2